SCHEMBL2064812

SCHEMBL2064812

CCOC(=O)[C@H](CC)NP1(=O)OC[C@H]2O[C@@H](n3ccc(N)nc3=O)[C@](C)(O)[C@@H]2O1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 3/20 0.36
▸ POLA1 P09884 2/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ SLC29A1 Q99808 1/20 0.36
▸ POLG P54098 2/20 0.34
▸ LMNA P02545 3/20 0.33
▸ CACNA1F O60840 2/20 0.33
▸ ALB P02768 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CACNA1D Q01668 2/20 0.33
▸ CACNA1S Q13698 2/20 0.33
▸ CACNA1C Q13936 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ MDM2 Q00987 1/20 0.33
▸ NCOA1 Q15788 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ STING1 Q86WV6 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ FGFR1 P11362 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2065038 0.94 POLA1 (0.36) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL2065464 0.93 POLA1 (0.35) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL14147838 0.92 PDE3A (0.37) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL2064784 0.92 PDE3A (0.37) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL2889203 0.91 PDE3A (0.38) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL16493643 0.87 POLA1 (0.35) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL2065433 0.86 POLA1 (0.35) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL2064244 0.86 — —
SCHEMBL10062708 0.85 POLA1 (0.36) PDE3APOLA1PDE4DSLC29A1POLG
SCHEMBL16502047 0.85 POLA1 (0.36) PDE3APOLA1PDE4DSLC29A1POLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148349-B2 Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2012-04-03 — — US disclosed
Send feedback